Prime Medicine, Inc. (Nasdaq: PRME) announced that the U.S. Food and Drug Administration has granted Regenerative Medicine Advanced Therapy (RMAT) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE